Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Endocrine Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm

Cancer Family

Endocrine Neoplasm

CI-CAN-00000015Explore in graph →

Non-malignant764 active trials16 approved drugs64 evidence items

NCIt: C3010

Overview
Statistics
Survival
Genomics20
Variants & evidence64
Drugs26
Trials2725
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

2,725 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 980 Recruiting 537 Unknown 398 Terminated 269 Active Not Recruiting 244 Not Yet Recruiting 170 Withdrawn 71 Enrolling By Invitation 20 Approved For Marketing 11 No Longer Available 10 Available 8 Suspended 7

PhaseAll Early Phase 1 44 N/A 335 Phase 1 609 Phase 2 1,190 Phase 3 217 Phase 4 44

No study matches these filters